CJC-1295 (No DAC), Ipamorelin

Description

(CJC-1295 5mg / Ipamorelin 5mg)

This peptide blend combines two well-studied growth hormone secretagogues, each with distinct mechanisms of action that target separate receptor pathways involved in GH regulation.

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that has been investigated for its ability to stimulate the GHRH receptor, leading to a natural increase in growth hormone (GH) release in experimental models.

Ipamorelin is a selective ghrelin receptor (GHS-R) agonist and has been studied for its ability to stimulate GH secretion without significantly affecting other hormones such as ACTH or cortisol. Research has explored its potential impact on muscle recovery, bone metabolism, insulin signaling, and gastrointestinal function in animal models.

When studied together, CJC-1295 and Ipamorelin have demonstrated synergistic activity in preclinical environments, suggesting complementary roles in modulating growth hormone pathways.

This product is intended for laboratory research use only. Not for human or veterinary use.

Description

What is CJC-1295?

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that stimulates the GHRH receptor, promoting the natural release of endogenous growth hormone (GH). In preclinical studies, CJC-1295 has been examined for its potential influence on bone density, lean body composition, muscle development, and insulin sensitivity.

When paired with Ipamorelin, a selective ghrelin receptor (GHS-R) agonist, the two compounds may produce complementary effects on the GH axis. Each peptide acts through a distinct mechanism, and their combination has been investigated in research models for its ability to enhance GH release without significantly increasing off-target hormonal activity.

Studies suggest that Ipamorelin may raise baseline GH levels, while CJC-1295 contributes to amplifying GH peaks and supporting pulsatile secretion. This dual approach may result in a higher overall GH set point, potentially supporting improvements in body composition, muscle recovery, metabolic balance, and glucose regulation in experimental settings.

This compound blend is intended strictly for laboratory research use only. Not for human or veterinary use.